Raymond James Financial issued a strong-buy rating for Seaport Therapeutics, which trades on the Nasdaq exchange.
1 report, 1 independent
Updated Fri 00:00
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Raymond James Financial issued a strong-buy rating for Seaport Therapeutics, which trades on the Nasdaq exchange.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Raymond James Financial
American Investment Bank and Financial Services Firm
-
Nasdaq
American fully electronic stock exchange
Related events
- Allegro MicroSystems stock is trading on the Nasdaq exchange, and Jefferies Financial Group has issued a buy rating, while MarketBeat aggregates consensus ratings.
- ProKidney and Cartesian Therapeutics were listed on the Nasdaq stock exchange and received ratings from MarketBeat.
- MarketBeat provides stock rating data for Vivos Therapeutics, which is listed on Nasdaq.
- Raymond James Financial issued a strong-buy rating on Equillium, which is listed on the Nasdaq exchange.
- Analyst reports published on MarketBeat regarding Tantech, a company whose stock trades on the Nasdaq stock exchange.